05
In this global pandemic D-BSSE is capable of tackling every aspect
The startup community is hit particularly hard by the global COVID-19 pandemic. The D-BSSE spinoff deepCDR Biologics is making the best out of this extraordinary situation - and realises that the pandemic provides the perfect platform to showcase the deepCDR technology and antibody discovery and development. Interview with the co-founder Derek Mason.
by Ulrike Haessler